🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with new zealand medsafe? Page 2

Has anyone dealt with new zealand medsafe?

newstart_MO Wed, Feb 18, 2026 at 11:31 PM 27 replies 1,132 viewsPage 2 of 6
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Feb 19, 2026 at 3:56 AM#6

One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

38 8DebRD_ATL, KristenIndy, MarkLI_maint and 35 others
Reply Quote Save Share Report
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Feb 19, 2026 at 5:40 AM#7

Following on from KevinCompounds — and this may be the naive question:

How long did you give it before you decided it was working?

37 7COA_Karl, MikeFit_NJ, InsuranceTom and 34 others
Reply Quote Save Share Report
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Feb 19, 2026 at 7:24 AM#8
VendorMark said:
Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a…

Adding the part of the answer the thread has not reached. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

36 6adam_van, Dr.SurgeonPGH, rachel_ABQ and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Feb 19, 2026 at 9:08 AM#9

Closing the loop on my own question.

Update, and it is the boring outcome: nothing was wrong. The measurement I was reading had moved less than its own week-to-week variation, which somebody said upthread and I did not believe.

35 5TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 32 others
Reply Quote Save Share Report
sean_dublin
Member
212
890
Nov 2024
Dublin, IE
Feb 19, 2026 at 5:27 PM#10
paige_pharma said:
It helps to ask what evidence would change your mind before you look at any.

That is correct as far as it goes, and here is where it stops going. Yes, and the corollary is less popular: if the reasoning holds, it also holds where it produces an answer we do not like.

43 16quinn_sf, NurseLeah_Nash, gary_naperville and 40 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register